Biomarkers for targeted rehabilitation strategies after breast cancer: Proposal for the next-generation management of survivorship issues  

作　　者：MARCO INVERNIZZI NICOLA FUSCO 

机构地区：[1]Translational Medicine,Dipartimento AttivitàIntegrate Ricerca e Innovazione(DAIRI),Azienda Ospedaliera SS.Antonio e Biagio e Cesare Arrigo,Alessandria,15121,Italy [2]Physical and Rehabilitation Medicine,Department of Health Sciences,University of Eastern Piedmont,Novara,28100,Italy [3]Division of Pathology,IEO,European Institute of Oncology IRCCS,Milan,20141,Italy [4]Department of Oncology and Hemato-Oncology,University of Milan,Milan,20122,Italy

出　　处：《BIOCELL》2022年第10期2221-2223,共3页生物细胞（英文）

摘　　要：Breast cancer(BC)is the most common malignant tumor and one of the top causes of cancer-related death worldwide(Sung et al.,2021).The recent advances in early tumor diagnosis coupled with more effective treatment strategies resulted in a steady increase of long-term survivors(Nardin et al.,2020;Invernizzi et al.,2022).These improved survival rates led to a significantly higher incidence of disabling complications related to breast cancer and/or its treatment(Invernizzi et al.,2020a;D’Egidio et al.,2017;Zhong et al.,2020).

关 键 词：Breast cancer Biomarkers SURVIVORSHIP Rehabilitation Precision medicine 

分 类 号：R73[医药卫生—肿瘤]